GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CrystalGenomics Invites Co Ltd (XKRX:083790) » Definitions » Debt-to-Asset

CrystalGenomics Invites Co (XKRX:083790) Debt-to-Asset : 0.14 (As of Mar. 2024)


View and export this data going back to 2006. Start your Free Trial

What is CrystalGenomics Invites Co Debt-to-Asset?

CrystalGenomics Invites Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩3,067.9 Mil. CrystalGenomics Invites Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩28,921.8 Mil. CrystalGenomics Invites Co's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2024 was ₩236,309.1 Mil. CrystalGenomics Invites Co's debt to asset for the quarter that ended in Mar. 2024 was 0.14.


CrystalGenomics Invites Co Debt-to-Asset Historical Data

The historical data trend for CrystalGenomics Invites Co's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CrystalGenomics Invites Co Debt-to-Asset Chart

CrystalGenomics Invites Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.24 0.20 0.22 0.22 0.13

CrystalGenomics Invites Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.27 0.21 0.23 0.13 0.14

Competitive Comparison of CrystalGenomics Invites Co's Debt-to-Asset

For the Biotechnology subindustry, CrystalGenomics Invites Co's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CrystalGenomics Invites Co's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CrystalGenomics Invites Co's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where CrystalGenomics Invites Co's Debt-to-Asset falls into.



CrystalGenomics Invites Co Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

CrystalGenomics Invites Co's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(2113.879 + 29889.276) / 243115.542
=0.13

CrystalGenomics Invites Co's Debt-to-Asset for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(3067.926 + 28921.755) / 236309.116
=0.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CrystalGenomics Invites Co  (XKRX:083790) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


CrystalGenomics Invites Co Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of CrystalGenomics Invites Co's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


CrystalGenomics Invites Co (XKRX:083790) Business Description

Traded in Other Exchanges
N/A
Address
5F, A-dong, Korea Bio Park, 694-1, Sampyeong-dong, Bundang-gu, Seongnam-si, Gyeonggi, KOR, 463-400
CrystalGenomics Invites Co Ltd Formerly CrystalGenomics Inc is one of the leading biopharmaceutical company in Korea. The company is mainly engaged in the research and development and new drug development. It develops innovative new drug development projects such as eradication antibiotics and molecular targeted anticancer drugs. It focuses on arthritic medicines and antibiotics which kill resistant bacteria. It also offers medicines for cancer, obesity, asthma, and diabetes.

CrystalGenomics Invites Co (XKRX:083790) Headlines

No Headlines